<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04114344</url>
  </required_header>
  <id_info>
    <org_study_id>WO_LAP</org_study_id>
    <nct_id>NCT04114344</nct_id>
  </id_info>
  <brief_title>Clinical Trial to Compare TAPP (Transabdominal Preperitoneal) vs TEP (Totally Extraperitoneal) y Approach for Women's Inguinal Hernia on an Outpatient Basis</brief_title>
  <acronym>WOLAP</acronym>
  <official_title>Randomized Clinical Trial to Compare TAPP vs TEP Approach for Women's Inguinal Hernia on an Outpatient Basis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Fundación Pública Andaluza para la gestión de la Investigación en Sevilla</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Fundación Pública Andaluza para la gestión de la Investigación en Sevilla</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Open prospective randomised clinical trial enrolling women who suffer from inguinal or
      femoral hernia, to evaluate if TEP approach is superior to TAPP concerning postoperative
      development, principally postoperative pain, with no increase of recurrent hernia at the
      one-year follow-up visit.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Randomised phase IV clinical trial enrolling women suffering from inguinal hernia in Virgen
      del Rocío University Hospital influence area, from March 2019 to March 2021.

      The aim of the study is to conclusively stablish whether there is real and significant
      benefit in using TEP approach over TAPP, in an outpatient basis, concerning postoperative
      evolution. Secondary objectives are the assessment of postoperative pain, using VAS (visual
      analogic scale), of both techniques, and evaluation of hernia recurrence during the first
      postoperative year The individuals will be assigned to each group according to simple random
      sampling.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">May 1, 2019</start_date>
  <completion_date type="Anticipated">March 2022</completion_date>
  <primary_completion_date type="Anticipated">February 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Post operative pain</measure>
    <time_frame>24 hours</time_frame>
    <description>Post operative pain, measured with Visual Analogue Scale (VAS) (from 0 to 10 points) World Health Organization (WHO)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Recurrence</measure>
    <time_frame>One year</time_frame>
    <description>Recurrence of inguinal hernia in the one-year follow-up</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Complications</measure>
    <time_frame>One year</time_frame>
    <description>Postoperative complications including wound complications (seroma, haematoma, infection), gastrointestinal complications (ileus, fistula), urological complications (acute retention, haematuria) and hernia complications (recurrence, chronic groin pain) will be reported. Occurrence of major complications will be registered, including intestinal injury, major vascular lesion, bleeding over 500cc and peritonitis.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Operating time</measure>
    <time_frame>180 minutes</time_frame>
    <description>Operating time from first incision to closure</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hospital stay</measure>
    <time_frame>24 hours</time_frame>
    <description>length of hospital stay will be measured in hours between the end of the surgery and the time of discharge.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">78</enrollment>
  <condition>Inguinal Hernia</condition>
  <arm_group>
    <arm_group_label>TAPP (Trans Abdominal PrePeritoneal)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Trans Abdominal PrePeritoneal approach to inguinal hernia repair</description>
  </arm_group>
  <arm_group>
    <arm_group_label>TEP (Totally Extra Peritoneal)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Totally Extra Peritoneal approach to inguinal hernia repair</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>TAPP</intervention_name>
    <description>Trans Abdominal Pre Peritoneal approach</description>
    <arm_group_label>TAPP (Trans Abdominal PrePeritoneal)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>TEP</intervention_name>
    <description>Total Extra Peritoneal approach</description>
    <arm_group_label>TEP (Totally Extra Peritoneal)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Inguinofemoral hernia, EHS (European Hernia Society) classification.

          -  Patient over 18 years old.

          -  Signed informed consent form.

          -  Female

          -  Meeting of outpatient discharge criteria, determined by Aldrete´s test

        Exclusion Criteria:

          -  Loss of domain.

          -  Abdominal skin grafts.

          -  Previous preperitoneal (open or laparoscopic) prosthetic mesh.

          -  Incarcerated hernia.

          -  Previous complications such as infection, fistulae…

          -  Not candidate for ambulatory surgery

          -  Pregnancy or desire for pregnancy in the first postoperative year
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>José Tinoco González</last_name>
    <phone>+34 625962094</phone>
    <email>Jose.tinoco.gonzalez@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Virgen del Rocío University Hospital</name>
      <address>
        <city>Sevilla</city>
        <zip>41013</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>José Tinoco González</last_name>
      <phone>+34 625962094</phone>
      <email>Jose.tinoco.gonzalez@gmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <verification_date>October 2019</verification_date>
  <study_first_submitted>September 12, 2019</study_first_submitted>
  <study_first_submitted_qc>October 1, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">October 3, 2019</study_first_posted>
  <last_update_submitted>October 1, 2019</last_update_submitted>
  <last_update_submitted_qc>October 1, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">October 3, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Fundación Pública Andaluza para la gestión de la Investigación en Sevilla</investigator_affiliation>
    <investigator_full_name>José Tinoco González</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>Woman</keyword>
  <keyword>Inguinal Hernia</keyword>
  <keyword>TAPP</keyword>
  <keyword>TEP</keyword>
  <keyword>Outpatient Surgery</keyword>
  <keyword>Ambulatory Surgery</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hernia</mesh_term>
    <mesh_term>Hernia, Inguinal</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Informed Consent Form</document_type>
      <document_has_protocol>No</document_has_protocol>
      <document_has_icf>Yes</document_has_icf>
      <document_has_sap>No</document_has_sap>
      <document_date>March 21, 2019</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/44/NCT04114344/ICF_000.pdf</document_url>
    </provided_document>
  </provided_document_section>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

